Fa2N-4 |
Transfection |
-
-
Possess, in comparison with cryopreserved human hepatocytes:
-
■
Significantly lower basal expression level of the nuclear receptor CAR and several drug metabolizing enzymes and transporters, namely CYP1A2/2D6/2E1/1A1, UGT1A1/1A6/2B15/2B4, sulfotransferase, NTCP, OCT1, OATP1B1/1B3, MRP2 and BSEP.
-
■
Markedly higher MDR1 mRNA levels.
-
■
Similar basal expression of BCRP, PXR and AhR.
-
■
Apparently higher expression of most transcription factors and coactivators/corepressors that have been associated with PXR and CAR mediated enzyme induction.
-
-
Are incapable of metabolizing compounds due to low basal levels of drug-metabolizing enzymes.
-
-
Exhibit, at early passage, inducible CYP1A2/2C9/3A4, UGT1A and MDR1 mRNA levels as well as CYP1A2/2C9/3A4 activities and could distinguish inducers from non-inducers. At higher passages, the cells lose the ability to induce.
|
Routine screening system for PXR-mediated CYP3A4 induction. |
(18,92,97) |
SV40 Tag |
HepLi5 |
Retroviral vector |
-
-
Express HBCF-X, GS, GST, ALB and CYP450 mRNA.
-
-
Retain ALB secretion and urea production, though at low levels compared to primary hepatocytes.
-
-
Display CYP1A2 activity.
-
-
Possess significantly enhanced cellular functions after large-scale culture in roller bottles.
|
|
(21) |
SV40 Tag |
HepLL |
Lipid mediated gene transfer (lipofectamine reagent) |
-
-
Display morphologic characteristics of liver parenchymal cells.
-
-
Express HNF4, HBCF-X, GST-Π and ALB mRNA as well as ALB and CYP2E1 protein but no ASGP mRNA.
-
-
Stain positive for human hepatocyte special antigen but negative for AFP.
-
-
Secrete ALB and urea at levels not significantly different from primary cultured human hepatocytes.
-
-
Synthesize glycogen.
|
Testing of new drug carriers for anti-HBV drug delivery. |
(22, 98) |
SV40 Tag |
HepZ |
Lipid mediated gene transfer (lipofectamine reagent) |
|
|
(47) |
Antisense constructions for Rb and p53 under control of ALB promoter + Cotransfection of E2F transcription factors and cyclin D1 |
HHE6E7T-1/2 |
Small hepatocytes |
-
-
Display epithelial-like morphology.
-
-
Retain characteristics of differentiated hepatocytes, though functions such as ALB secretion as well as mRNA expression levels of ALB, HNF4 and A1AT decrease gradually as the passages progress. CK18 mRNA levels are detected throughout the culture period and no AFP expression is observed.
-
-
Are positive for vimentin staining.
|
|
(16, 99) |
Lentiviral and retroviral vectors |
HPV16 E6/E7 + hTERT |
HHL(-5/-7/-16) |
Retroviral vector |
-
-
Contain markers of hepatocyte and biliary phenotype (CK7/8/18/19).
-
-
Express CYP450 protein at levels comparable to Huh-7 and HepG2 cells.
-
-
Produce ALB, though at lower levels than Huh-7 and HepG2 cells.
-
-
Stain negative for AFP and do not display elevated nuclear expression of p53 protein.
-
-
Possess active gap junctions.
-
-
Respond to INF-α stimulation by upregulation of major histocompatibility complex I and II
-
-
Exhibit, in contrast to the Huh-7 and HepG2 cells, increased capacity to bind recombinant hepatitis C virus-like particles.
|
Used as a cell model to investigate:
-
-
Ability of CD8+ T-cells to recognise and kill hepatocytes under cytokine stimulation.
-
-
Role of sirtuin 4 in energy homeostasis.
-
-
Effect of THCV on insulin signalling in insulin-resistant human hepatoctyes.
-
-
Gene expression and antigen presentation after adeno-associated viral transduction and effect of proteasome inhibition or capsid mutation.
|
(15, 89-91, 100-102) |
HPV16 E6/E7 |
IHH-A5 |
Lipid mediated gene transfer (lipofectin reagent) |
-
-
Are morphologically and functionally more similar to hepatoma cell lines than primary hepatocytes in culture.
-
-
Secrete different plasma proteins, including ALB, APO-B and fibrinogen at relatively high rates, within the range observed for early primary human hepatocyte cultures. Addition of IL-6 to the culture medium results in increased fibrinogen secretion and decreased ALB production, demonstrating a proper acute-phase response.
-
-
Produce detectable amounts of APO-A1.
-
-
Exhibit bile-canalicular structures that, in some cases, accumulated the organic anion glutathione-methylfluorescein. Cell cultures are partly polarized and express the efflux transporters, MDR1 and MRP1, on the membranes of apical vacuoles or on the lateral membranes of adjacent, proliferating cells, respectively.
-
-
Do not maintain active Na+ -dependent bile salt uptake.
-
-
Display similar lipoprotein metabolism as HepG2 cells.
|
Used a cell model to investigate:
-
-
Molecular mechanisms underlying FXR regulation of ChREBP transcriptional activity in human hepatocytes.
-
-
Effect of antipsychotic drugs on SREBP transcription factor pathways which control.
-
-
Role of c-fos expression on hepatocyte cell motility and cell cycle regulation.
-
-
Effect of cadmium on nonmalignant human hepatocytes.
|
(23, 85, 86, 103-105) |
SV40 Tag |
PH5CH |
Lipid mediated gene transfer (lipofectin reagent) |
|
Used a cell model to investigate:
-
-
HCV infection, replication and tropism.
-
-
HCC-selective cytotoxicity of HBF-0079.
-
-
MicroRNA expression in TGF-β-induced hepatocyte EMT.
-
-
Effect of hepatitis B virus proteins on signalling mediated by members of the Toll-like/interleukin 1 superfamily.
-
-
Effect of HBV polymerase on IFN production in human hepatocytes.
|
(25, 74, 75, 81, 106-113) |
SV40 Tag |
THLE |
Retroviral vector |
-
-
Display epithelial morphology.
-
-
Secrete ALB and express CK18, TF, A1AT, A2M, GST-Π and very low levels of GGT at early passages. CK19 expression can only be determined at later passages. Cells are uniformly negative for AFP and factor VIII. The appearance of CK19 and decreased ALB secretion at later passages demonstrate that cells undergo dedifferentiation in culture.
-
-
Retain mRNA expression of phase II enzymes such as EH, catalase, GPX, SOD and GSTs at levels comparable to human liver, with GST-Π and a mRNA as the dominant form in THLE cells or human liver, respectively.
-
-
Maintain NADPH CYP reductase expression at a lower steady-state mRNA level than in human liver.
-
-
Are able to metabolize three carcinogens, which suggests the presence and activity of CYP1A2/1A1, CYP2E1 and CYP3A4. However CYP1A2, CYP2E1, CYP3A4, CYP2A3 and CYP2D6 mRNA are not detected. The steady-state mRNA levels of CYP1A1 increase after exposure to Aroclor 1254 or B[α] P.
|
THLE and THLE-CYP cells can be used to study cellular toxicity of compounds. Used a cell model to investigate:
|
(25, 93, 94, 111, 114-124) |
SV40 Tag |
TPH1 |
Strontium phosphate precipitation |
-
-
Exhibit altered cell morphology resembling low-differentiated epithelial cells.
-
-
Express no A1AT or AFP mRNA.
-
-
Secrete ALB.
-
-
Possess G6P activity.
-
-
Reactivate telomerase immediately after senescence.
|
Used a cell model to investigate HCV infection and replication.
Induces apoptosis of activated hepatic stellate cells. |
(45, 77, 78, 125-129) |
HCV core gene |